The 12-strong crew, aged between 18 and 60, left Marina San Miguel, Tenerife on 22nd March and rowed 2,875 nautical miles across the Atlantic Ocean, arriving in Falmouth Harbour, Antigua 42 days, 2 hours and 30 minutes later.
Each of the crew of the 12-metre boat, Roxy, rowed more than 1.5million strokes and burned over 5000 calories a day.
During the journey, the team had to battle with ocean storms and seasickness, not to mention extreme blisters and callouses. Simon lost almost 10kg.
Simon, who was a rowing novice before this, raised almost £15,000 for MacMillan Cancer Support. He said: "It’s without a doubt the hardest thing I’ve ever done. I can’t put into words how I’m feeling right now. The sense of achievement is a little overwhelming.
"The journey was everything I wanted it to be - tough both physically and mentally but hugely rewarding and one thing is for sure, I wouldn’t be standing here at the finish line if it hadn’t been for each and every one of the incredible crew. What a gorgeous group of people who will remain lifelong friends. After catching up with my family, the thing I was most looking forward to was a good meal!”.
The crew were welcomed to Antigua by a flotilla of smaller boats with many of the crew’s families onboard, before a reception at the Antigua Yacht Club.
Culture Change In Healthcare is presented by Simon Fleming, a trauma and orthopaedic registrar who has a special interest in combating bullying, undermining and harassment in human healthcare, and Sally Everitt MRCVS, the ex Head of Scientific Policy at BSAVA.
Simon will discuss the problem of bullying, the fallout from serious cases, and how you can work to eliminate bullying in your practice.
Sally will present the results of a survey carried out by VetSurgeon.org and VetNurse.co.uk in 2017, to investigate the incidence and impact of unpleasant behaviour in veterinary practice.
The webinar is hosted by The Webinar Vet and sponsored by RCVS Mind Matters. It counts as 1hr towards your annual CPD requirement.
Whether or not you think there is any bullying going on at your practice, I strongly urge you to watch this webinar. There can be few things as harmful to an effective practice team as bullying. Everyone needs to be able to spot it and stamp on it quickly.
Register for the webinar here: https://www.thewebinarvet.com/pages/culture-change-healthcare-2/
Virbac has launched Inflacam, a meloxicam-based NSAID for the alleviation of pain in both acute and chronic musculo-skeletal disorders in dogs and horses.
Inflacam is presented both as an oral suspension and as a chewable tablet for dogs. The suspension is available in 200ml, 100ml, 42ml and 15ml sizes with a measuring syringe provided. The tablets come in two sizes - 1 mg and 2.5 mg - and are available in packs of 100. It is available for horses as an oral suspension.
Virbac Product Manager Chris Geddes MRCVS, said: "Virbac is well known for launching innovative products in areas such as dermatology and reproduction but we also aim to support practices by offering tried and trusted practice 'standards' for everyday use. Inflacam fits this brief well - meloxicam is the most commonly-used NSAID in dogs and we are delighted to add it to our range."
For more information contact your territory manager or call Virbac on 01359 243 243.
New research published in the Equine Veterinary Journal (EVJ) has shown that the use of standing sedation to repair lower limb fractures in racehorses produces similar results to surgery performed under a general anaesthetic, but with the advantages of less surgical complexity, time, cost and risk.
The study Short and long term results following standing fracture repair in 34 horses was conducted by Richard Payne and Polly Compston at Rossdales Equine Hospital1.
Standing fracture repair in the horse is a relatively new surgical procedure with very little follow-up data available. Treatable fractures sustained by racehorses in the UK have traditionally been repaired under general anaesthesia but it is well known that this carries an increased risk of anaesthetic-related death compared with other elective surgical procedures. However, despite the substantial increase in the number and type of surgical procedures performed under standing sedation over the past decade there has previously been very little work undertaken on standing fracture repairs.
The study looked at the case records of 34 Thoroughbred and Arab racehorses that had a lower limb fracture surgically repaired by one surgeon at Rossdales up until June 2011. The injuries included non-displaced fractures of the proximal phalanx, the third metacarpal bone and the third metatarsal bone, all of which are relatively common fracture sites in racehorses. Hospital records, owner and trainer telephone questionnaires and website research were used to evaluate follow-up. The short and long-term results were similar to those of horses undergoing repair of comparable fracture configurations under general anaesthesia, with 20 of the horses returning to racing within an average of 226 days.
This early research indicates potential for tangible benefits, including avoidance of the inherent risks of general anaesthesia as well as a reduction in surgical complexity and associated costs, leading the way for future research into larger cohorts of horses.
EVJ's Editor Celia Marr said: "The recent fatalities at the Grand National highlight that it is critical that the equine veterinary research community strives to reduce the prevalence of fractures in our racehorses. We also need to continue to seek better ways of treating those horses that do develop fractures and, while not every fracture will be amenable to this approach, this study is an important first step towards treating some of the non-displaced fractures that occur in racehorses without the need for anaesthesia."
1Short and long term results following standing fracture repair in 34 horses Richard Payne and Polly Compston, Equine Veterinary Journal ISSN 0425-1644 DOI: 10.1111/j.2042-3306.2012.00569.x
The Council of the Royal College of Veterinary Surgeons has approved a new Health Protocol, which formalises a more compassionate approach to veterinary surgeons with health problems.
The Protocol will allow - in appropriate circumstances - veterinary surgeons (and, from next year, registered veterinary nurses) who suffer from health concerns affecting their ability to practise safely, to have the matter dealt with confidentially, without going to a full public Disciplinary Committee hearing.
It will allow individuals to access appropriate support and help away from the public spotlight, while ensuring that they do not put animals or the public at risk.
According to independent legal advice sought by the College, such an approach is appropriate and necessary in order for the College to fulfil its regulatory responsibilities - similar systems exist within other regulators.
The draft Protocol was the subject of consultation amongst the profession and the public over summer. Proposed amendments to the RCVS Guide to Professional Conduct, to support the introduction of the Health Protocol, were also approved in the November meeting.
RCVS Head of Professional Conduct, Gordon Hockey said: "The Protocol encourages anyone coming into contact with veterinary surgeons - including other veterinary surgeons, veterinary nurses, members of practice staff, clients and healthcare professionals - who have concerns about a veterinary surgeon's health to report those concerns to the RCVS as soon as is reasonably practicable.
"Veterinary surgeons and veterinary nurses who are concerned about the health of a veterinary surgeon must also take steps to ensure that animals are not put at risk and that the interests of the public, including those of their colleagues, are protected."
Procanicare contains three live strains of canine-specific Lactobacillus bacteria, which, according to the company, make it an ideal GI support product to maintain balance in the GI intestinal microbiome of dogs, particularly when an alteration to the intestinal microbiome is a risk.
Animalcare says studies show that the strains of Lactobacillus found in Procanicare have been shown to promote indigenous intestinal commensal populations, reduce numbers of potentially pathogenic bacteria and improve stool consistency.1,2
Dr Shea Beasley, Product Development Manager at Vetcare Ltd said: "The strains of Lactobacillus found in Procanicare have been commercially available in Scandinavia for two years now. It has achieved great success, with Scandinavian vets frequently recommending it in situations where the gastrointestinal microbiota can become unstable such as following antibiotic use and in stressful situations such as travelling and kennelling, as well as when supporting the intestinal microbiome is particularly important, such as during pregnancy and lactation."
Available exclusively through vets, Animalcare has produced a range of waiting room materials to help you educate about and promote Procanicare in practice, including a poster, bunting, leaflet and leaflet holder.
There is also a free webinar for veterinary professionals on the importance of the intestinal microbiome, available to view at www.thewebinarvet.com/webinar/the-gastrointestinal-microbiome-and-its-effects.
To find out more or to try Procanicare in your practice, contact your local Animalcare representative via email animalcare@animalcare.co.uk or telephone 01904 487687 or visit www.procanicare.com.
References
Normally only accessible by ISFM members, the channel has been opened up as a free resource to help vets keep on top of CPD and includes over 40 webinars presented by internationally recognised veterinary specialists.
Topics include: anaesthesia and analgesia, behaviour, emergency and critical care, feline medicine and neurology. Each webinar is worth 1 hour of CPD and you get a certificate.
The channel includes a new webinar: ‘COVID-19 – helping cats cope’ which looks at how you can advise owners to help their cats deal with changes at home.
ISFM’s Feline Medicine Consultant, Sam Taylor said: "ISFM is committed to educating veterinary professionals on all things feline, so we are delighted to be able to bring some of our normally member-only benefits to a wider audience during this challenging time."
To register for the ISFM webinar channel, visit: https://icatcare.org/event/isfm-vet-webinars/
Together, these two cancers account for almost a third of all canine cancers.
Dr. Heather Wilson-Robles, an Associate Professor at Texas A&M University and Chief Medical Officer of Volition Veterinary Diagnostics said: "The proof of concept results in these two very prevalent canine cancers give us confidence to move forward with other Nu.Q Vet assays in our pipeline, and with the larger range of cohorts and trials we have collected and planned.
"Clearly, we still have work to do as this single assay did not detect one of the other top five canine cancers, canine osteosarcoma, which was the third cancer tested in this study. However, I am delighted to see such positive results in these two significant cancers and look forward to reporting further data over the coming quarters with additional Nu.Q Vet assays, this time tested on an automated platform.”
Dr. Terry Kelly, Chief Scientific Officer of Volition America said: “It is exciting to see such strong results from our first Nu.Q Vet study conducted at Texas A&M University Veterinary Hospital. It is also interesting to note the similar patterns of detection seen in both canine and human samples confirming that the Nu.Q platform does appear to be useful in more than just human diagnostics.
"As with human diagnostics, there are currently no accurate, simple, affordable cancer screening tests available in veterinary medicine and yet 25% of dogs will develop cancer at some stage of their life. I look forward to completing the planned trials and to launch our first Nu.Q Vet product in the U.S. that we expect to occur in 2020."
On top of that, over 25% of vets said they don't talk to their farmer clients about the disposal of empty pharmaceutical waste.
The survey also found that while veterinary surgeons are aware that both glass and shatterproof plastic vials are incinerated, over 65% of those questioned believed that glass vials were more environmentally friendly, when in fact, the company says its CLAS (Ceva Layered Anti Shatter) shatterproof plastic vials have 33% less impact on the environment from cradle to grave2.
Ceva is producing a range of support materials, including tailored social media and newsletter content, to help vets to raise awareness of their pharmaceutical waste disposal service and drive improvements across the industry.
Peter Keyte, ruminant business unit manager at Ceva Animal Health said: "As an industry we should be doing all that we can to improve our environmentally friendly credentials.
“Ceva will continue to invest in innovative eco-friendly technology for livestock injectables and pioneer improvements to help ensure best practice throughout the industry.”
For further information, or to request a pharmaceutical waste disposal service support pack, contact your local Ceva account manager or call 01494 781510.
Bringing together people working at the cutting edge of small animal and equine osteoarthritis treatment with the companies driving technology, supplies and services, the Veterinary Osteoarthritis Congress is open to both VOA members and non-members, including veterinary surgeons, nurses, physiotherapists and others engaged in hydrotherapy and rehabilitation.
Day 1 has two small animal streams – session headings include ‘Managing OA’ and ‘Dealing with chronic pain’; and an equine stream looking at ‘Multidisciplinary management of OA’, ‘OA treatment options’ and ‘Unusual presentations’.
On day 2, ‘Biomodulation in OA’, ‘Working dogs’, ‘Mobility clinic’, and ‘Feline OA focus’ will run alongside sessions on ‘Rehab in action’, ‘Surgery in OA’ and ‘Dietary supplements’.
There’ll also be case presentations and interactive sessions on both days, with demonstrations and lectures from some of the leading firms.
Seven sessions in each stream offers two days of CPD.
After the first day’s sessions there’ll be a happy hour followed by a gala dinner in the Kings Hall. The event is being sponsored by Animalcare (Platinum), TVM UK and the Canine Hydrotherapy Association (Gold) with more to be announced soon.
Professor Stuart Carmichael, co-founder and director of the VOA, said: “Exciting developments are happening in veterinary OA, so we felt now is the right time to put this event on.
"There’s nothing specialist about osteoarthritis treatment and management: every small animal and equine practice deals with OA every day.
“There’s a real need and enthusiasm for bringing the latest thinking to as wide an audience as possible, so VOACON offers sessions for all members of the practice, whatever their interest is, along with rehab and physio teams.
"It’s actually been pretty difficult fitting everything in, but we’re confident we’ve got a great programme offering real, practical CPD that will benefit practices, their clients and their patients.”
Delegate rates for VOA members are:
Non-members (who can join the VOA when booking to qualify for members’ rates):
Rates include a hot buffet lunch, congress book and CPD certification.
To book or to download the programme, visit www.vet-oa.com/voacon.
Pfizer's Vet Support+ has launched the Practice Management Academy, which offers online training in the key management disciplines required to run a successful veterinary business.
There are twelve courses which cover four key areas of management: financial operations, staff management, client relations and marketing. Participants can choose to study individual courses, a specific area of management, or enrol in the full Practice Management Academy.
The courses are four weeks in length and contribute up to ten hours of CPD learning through a mix of interactive activities, case studies, questions and a student learning forum.
Each course is also allocated a Pfizer Business Consultant to work as an online expert tutor, posing questions and stimulating forum discussion amongst the students.
Pfizer says that the significant cost saving e-learning represents over external CPD is making the Academy a popular choice for all members of the practice team, especially those who may be taking on new management responsibilities or those looking for a refresher. According to the company, one large vet group has already taken twenty places on each of the courses to improve the practice management skills across its extensive team.
Ned Flaxman, Director Business Innovation said: "Using an E-Learning platform is a well-trodden path, ideal for busy individuals wishing to improve or gain new practice management skills without leaving the surgery, or sofa. However, unlike some e-learning which can leave the participant feeling like they are gaining theoretical know-how only, and working in somewhat of a silo, our Academy offers an 'online campus'. This provides a flexible, convenient and supportive training environment for shared theory and practical learning with other colleagues from the veterinary profession under the guidance of e-tutors and experts."
For further details visit http://www.vetsupportplus.co.uk/
Sheila Wills BSc BVetMed CertSAM DipECVIM-CA MRCVS, specialist in internal medicine, has joined Wey Referrals, the Surrey-based multi-disciplinary veterinary referral practice.
Professor John Innes, Referral Director at CVS (of which Wey Referrals is a part) said: "We are delighted to welcome Sheila to our specialist team at Wey Referrals. Her experience and knowledge will further strengthen the service we offer and her appointment is another important step in the development of our referral team in the South East. Attracting the highest calibre talent is important to CVS because we want to build a referral team, whose members are not only clinically excellent but who also possess first rate communication and inter-personal skills."
Sheila said: "I am excited to be joining the CVS specialist team and look forward to working with like-minded colleagues who are passionate and dedicated to providing the highest level of patient care and client communication. I am delighted to be able to offer a specialist internal medicine service in both feline and canine medicine and look forward to offering a comprehensive service to CVS clients and expanding the internal medicine service further in the future."
Sheila graduated from the Royal Veterinary College in 1998 and spent five years in small animal practice before undertaking an FAB Residency in Feline Medicine at the University of Bristol.
Shortly after her residency, she was appointed Head of Small Animal Medicine and the Feline Centre at the Animal Health Trust where she was based for two years before moving to a major veterinary laboratory in December 2009. She recently returned to the University of Bristol as a teaching fellow in feline medicine.
Sheila acquired her ECVIM Diploma in Internal Medicine in September 2010 and is a Recognised European Veterinary Specialist in Internal Medicine. She became an RCVS Recognised Specialist in Feline Medicine in March 2012 and enjoys all aspects of feline medicine with a specialist interest in feline renal and ureteric disease. She is a member of the ICC Feline Expert Panel and an editorial board member for the Journal of Feline Medicine and Surgery.
Idexx Laboratories has launched a new renal function test, Idexx SDMA, which the company says can detect chronic kidney disease (CKD) in dogs or cats months or even years earlier than traditional methods.
The test is based on a new renal biomarker - symmetric dimethylarginine (SDMA) - and is the result of collaboration with a number of global experts.
Simon Wootton, UK CAG Marketing Manager at Idexx said: "The high sensitivity of this marker for detecting CKD will allow vets to diagnose the disease a lot sooner than has been previously possible. Identifying the disease earlier will give vets more time to intervene and prescribe an appropriate course of action."
The company says that the Idexx SDMA test can identify renal disease in dogs up to nine months earlier than previous methods, while in cats the detection time can be up to 17 months earlier.
Dr Martha Cannon, BA VetMB DSAM(fel) RCVS Recognised Specialist in Feline Medicine of the Oxford Cat Clinic, said: "The launch of SDMA testing is very exciting. It offers the prospect of identifying chronic kidney disease at an earlier stage, which should mean we can treat it more effectively and allow us to maintain cats in the asymptomatic phase. This can improve longevity, but more importantly could help maintain a better quality of life for longer.
"SDMA is also unaffected by muscle loss, which will allow us to assess the true extent of CKD in our elderly and underweight cats. This will lead to improved treatment choices, better quality of life and more peace of mind for owners."
The value of the new test has been validated by the adoption of SDMA into the International Renal Interest Society (IRIS) guidelines as a biomarker for the early detection of CKD.
Jonathan W. Ayers, President and Chief Executive Officer of Idexx Laboratories, said: "Idexx SDMA is a result of our commitment to lead the industry in sustained research investments that serve to advance veterinary medicine. It represents a significant achievement in veterinary diagnostics. Hospitals in the USA already using Idexx SDMA have told us that it has transformed the way renal disease is diagnosed and treated."
Idexx SDMA is available to UK and Ireland reference laboratory customers now. Further information is available at www.idexxsdma.com.
Video shows Sylvia Conway MRCVS, UK Medical Affairs Consultant at Idexx, talking about the new test (can also be viewed here).
'Period prevalence and mortality rates associated with hypocholesterolaemia in dogs and cats: 1,375 cases1' determined the period prevalence of hypocholesterolaemia and the associated mortality rates in dogs and cats at the Veterinary Medical Teaching Hospital, University of California, Davis.
The medical records of cats and dogs presenting to the hospital from 1st September 2011 to 30th August 2016 were retrospectively reviewed to identify all animals that had at least 1 cholesterol measurement; a total of 16,977 dogs and 3,788 cats were identified. Patient signalment and clinical information were collated from the medical records, including the primary disease processes in patients with moderate to severe hypocholesterolaemia. The period prevalence and mortality rate of hypocholesterolaemia were calculated.
The period prevalence of hypocholesterolaemia was 7.0% in dogs and 4.7% in cats. The mortality rate of hypocholesteraemic dogs and cats was 12% in both species, which was significantly higher than that of animals with normal serum cholesterol.
Steven Epstein, corresponding author for the paper, said: 'The odds of death in dogs and cats with hypocholesterolaemia were 3.2 and 2.5 times higher than in those with normocholesterolaemia respectively. Furthermore, there was a significant linear trend towards higher mortality in association with more severe hypocholesterolaemia in both species.
'Disease of the hepatic, gastrointestinal and lymphoreticular systems were most commonly associated with hypocholesterolaemia, and infectious and neoplastic disease were the most commonly associated pathophysiological processes in both species. In dogs with neoplasia, lymphoma was over-represented.'
Nicola Di Girolamo, Editor of JSAP said: 'These findings suggest that low cholesterol levels are associated with mortality in canine and feline patients. It is not clear whether hypocholesterolaemia is simply a marker for disease severity, or if it has active physiological effects contributing to poor outcomes. At this stage, it seems indicated to enhance intensity of diagnostic effort and therapy for affected animals.'
The full article can be found in the November issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13204
Reference
Available in packs of 56 (4 x 14 tablet blister packs), Lodisure tablets are divisible for accurate dosing.
The recommended starting dose is 0.125-0.25 mg amlodipine per kg bodyweight per day, which equates to half a tablet for cats weighing less than 4kg (and more than 2kg) and one tablet per day for cats weighing between 4kg and 8kg.
It can be administered directly to the cat or given with a small quantity of food.
Dechra companion animal brand manager, Sarah Musgrave, said: “Feline hypertension is very often part of a more complex diagnosis, therefore it is important that antihypertensive therapies are easy to dose and administer.
"Lodisure is a new, first-line, easy to dose and administer treatment to control systolic blood pressure in cats while the underlying primary cause is diagnosed and treated, which vets can rely on in their day-to-day practice.”
https://www.dechra.co.uk/products/cat/prescription/lodisure.
The Veterinary Marketing Association has announced details of a new award for public relations, open to veterinary practices and companies.
The VMA says this award is to recognise the value that media and public relations can add to the marketing mix. It will be awarded to the company or veterinary practice that has delivered the most innovative PR campaign during 2011, as judged by a panel of industry professionals.
Organiser Claire Edmunds said: "The VMA Awards has become a coveted event for those involved in the animal health industry to showcase their marketing achievements. A range of categories has evolved since the awards began over 20 years ago, for marketing, creative communication and new media campaigns. However, we felt that an award for PR was required to complete the marketing mix".
Jane Manning from award sponsor Splash Marketing & Communications said: "We felt it was time to give the opportunity for those involved in PR to obtain the recognition they deserve alongside their creative colleagues.
"An effective PR campaign can be a highly influential marketing tool, so it's great news that the VMA has added this new award category. We hope that companies and agencies serving the animal health sector will embrace this new opportunity to showcase their creativity and hard work".
The award is for the most innovative PR initiative published during the year. This can be a single 'one-off' event or article, or a sustained campaign over a given period. The winner and two highly commended entries will be awarded at the VMA Awards on Friday 9th March 2012 at Shakespeare's UnderGlobe Theatre, London.
Further information on the awards and ticket application forms are available at the VMA's website - http://www.vma.org.uk/ or by calling 0844 561 6157. The deadline for entries is Friday 27th January 2012.
The RCVS Disciplinary Committee has suspended a Co. Tyrone veterinary surgeon from the Register for ten months, having found him guilty of serious professional misconduct relating to three convictions for contravening animal export regulations.
Whilst working as an Authorised Veterinary Inspector in Castlederg for the Department of Agriculture and Rural Development (DARD), William Manson had falsely certified that he had inspected three consignments of sheep presented for assembly at Plumbridge Export Assembly Centre on 16 and 23 August 2009. At this week's two-day hearing, Mr Manson admitted that the convictions he had received at the Strabane Magistrates Court on 26 November 2010 made him unfit to practise veterinary surgery, but said in mitigation that he had examined the sheep nearby at Landahussy, a site he considered more suitable for a large number of animals.
The Committee was satisfied that Mr Manson believed the Landahussy site to be more suitable for large deliveries; the Committee also was satisfied that he did carry out a visual inspection of the sheep at the Landahussy site on 16 and 23 August 2009. However, the information Mr Manson provided on the three certificates was false and misleading. Mr Manson had also been reminded of the importance of complying with government regulations in a disciplinary case in 2004, following convictions for failing to notify DARD about changes in the number of sheep for which he was claiming a premium. The then Committee dismissed the case, deeming the convictions a result of his "genuine but regrettable oversight".
Speaking on behalf of the Committee, Chairman, Prof Peter Lees said: "Mr Manson's actions in certifying that he had examined the sheep at an approved assembly centre when he had not done so amounted to a serious departure from professional standards. If there had been a disease outbreak on either the Plumbridge or Landahussy site, such actions would have rendered contact tracings unreliable and inaccurate."
In mitigation, the Committee accepted medical evidence and Mr Manson's testimony that he was at that time under exceptional stress. He was working long hours in difficult circumstances without an assistant, and was under considerable personal pressure as a result of his wife's serious illness. It also took into account his age (66), exceptional testimonials produced on his behalf, and the impact on the community he served.
Prof Lees said: "The Committee has concluded that the removal of Mr Manson's name from the Register is neither proportionate nor necessary in the public interest nor to protect the welfare of animals. A proportionate sanction in this case is to suspend Mr Manson's name from the Register for a period of ten months."
Direct Line has revealed the results of a small survey which found that 78% of veterinary surgeons had treated pets for ingesting human medicines in the last year.
100 vets took part in the study, of which 28% reported that they had cases where owners had deliberately given their pet human medication in an attempt to help them. Some vets described incidents of owners believing paracetamol will help conditions like arthritis and limping. In one case an owner gave their cat a quarter of paracetamol every day in an attempt to stop its pain, which instead resulted in the cat dying.
The most common types of medication ingested were:
In total, the veterinary surgeons who took part in the survey reported 243 cases of accidental ingestion of human medicines. The majority (76%) of cases involved dogs. However incidents involving cats, rabbits and guinea pigs were also reported.
The recommendation follows the analysis of data collected as part of the company's Talk About Laminitis disease awareness initiative, which has seen more than 47,000 horses tested for PPID since it was launched in 20121.
The data revealed that, regardless of presenting clinical signs, a horse aged 15-20 is three times more likely to have PPID compared to a horse under 10, and this risk increases with age. For example, a horse of 20-25 is six times more likely to have PPID compared to a horse under 10 and a horse that is 25-30 is 10 times more likely to have PPID.
Boehringer says that despite the high prevalence of PPID in the older horse population, the clinical signs of the disease are insidious in onset and owners may simply associate them with the ageing process.
One study demonstrated that in a single population of horses over the age of 15 only 1.6% of owners reported signs of PPID2. However, when the same group of horses were examined by a veterinary surgeon, 21% were found to have signs of the disease.
Dr Jo Ireland, veterinary surgeon at the University of Liverpool, said: "It is often difficult for owners to spot the signs of PPID as they frequently associate them with the ageing process. However, PPID is now the fifth most commonly diagnosed disease in horses in the UK3.
"We are therefore encouraging veterinary surgeons to routinely test horses over 15 years of age or those that are displaying signs of PPID with an ACTH test."
The 'Talk About Laminitis' disease awareness initiative runs from June until the end of October and aims to raise awareness of the underlying hormonal causes of laminitis – PPID and Equine Metabolic Syndrome (EMS). As part of the scheme, the laboratory fees for the blood test which detects PPID (the basal ACTH test) are free.
Redwings’ head of veterinary and care, senior veterinary surgeon Nicky Jarvis, said: "Any initiative that decreases the incidence of laminitis developing in an older equine is invaluable. Laminitis is an extremely distressing condition for both the horse and the owner and the long-term consequences can be devastating. Knowing the underlying cause is a huge help in tackling the disease and we would encourage anyone to take advantage of this offer and get their veteran checked out."
For further information about 'Talk About Laminitis', visit www.talkaboutlaminitis.co.uk or contact your local Boehringer Ingelheim account manager.
The company says its service has been designed to help practices take a proactive approach to managing their workforce, keeping them out of the employment tribunal and providing continued support to help them achieve their goals.
Melanie Davies, Head of Employment at MS Rubric (pictured right) said: "Whether a business employs 5 people or 500, is a start-up, or has been successfully trading for years, it is critical that it has a reliable legal advisory system in place to manage the range of challenges that arise.
"All businesses need to be able to access a professional source of advice and guidance to meet their objectives for best practice, compliance or to meet commercial goals and targets.
"With legislation changing so frequently, this legal expertise is sometimes missing from some businesses. As business owners realise its importance, they are relying more on external HR and legal experts like ourselves to provide this service. We think it’s so important, we are making this available to all sectors of business.”
MS Rubric adds that all its advice is covered by legal professional privilege. This means that unlike when businesses use HR or other consultancies, conversations between MS Rubric and its clients remain confidential and disclosure is not required.
For more information, contact Melanie Davies on 01454 800008 or mel.davies@msrubric.co.uk.
The Congress, which is organised by Improve International, has separate streams for small animal medicine and small animal surgery and a dedicated veterinary nursing stream.
There will also be an exhibition of the latest innovations in veterinary products and services running alongside the lectures.
Helen Richmond, Head of Publishing at Improve said: “While technological innovation has made online congresses much more engaging and accessible over the last year, we felt the time was right to bring Vets North back in a face-to-face environment. Many of our previous delegates have already told us how much they are looking forward to being able to learn and enjoy some social time together again.
“As usual this year’s programme will include presentations and lectures from global experts, who will give advice and share knowledge that can be implemented in practice immediately. We would like to thank Elanco as our lead sponsor of this year’s Vets North and we also thank our other partners and sponsors for their support and loyalty during this difficult year.”
"Naturally, keeping delegates safe is our highest priority so we are working with the venue to ensure that the Government’s recommendations are implemented to the full and that Haydock Park is a COVID-secure venue.”
Early Bird tickets are available until the end of June.
For more information visit www.vetsnorth.com or call 01793 20805.
Cranial cruciate ligament insufficiency (CCLI) affects 3% to 5% of dogs1.
Past research has demonstrated satisfactory short (6-12 weeks)2 and medium (mean 16 months)3 term outcomes for lame dogs treated with TTA.
However, Steve says there is limited research on longer (>16 months) follow-up periods.
It has also been speculated that dogs with tibial plateau angles (TPA) of greater than 30⁰ are not well suited for a TTA4.
For the study5, the researchers reviewed patient records for a total of 149 TTA-Rapid procedures carried out in 120 dogs over an 80 month period.
They also reviewed owner questionnaires that evaluated the outcome of at least six months after surgery, using a validated clinical metrology instrument, Liverpool Osteoarthritis in Dogs (LOAD).
Follow-up questionnaires were received from owners of 64 of the 120 dogs (53.3%), with a median follow-up time of 37.5 months.
This cohort included a wide range of breeds, aged between 2&12 years and with bodyweights ranging from 6.3 to 41.8kg.
The dogs included 37 females and 27 males, and of the 79 limbs treated in these dogs, 41 were left and 38 were right.
The researchers found 26 of the dogs (40.6%) had a TTA performed with a TPA less than 30◦ and 38 (59.4%) with a TPA of 30◦ or more.
Of the 79 procedures, meniscal injury was noted in 27 (34.2%), surgery to stabilise the patella was required in 11 (13.9%), there was one surgical site infection (treated successfully with a short course of antibiotics), one dog sustained a fracture of the tibial seven days after surgery, and one sustained a late meniscal tear 12 months after initial surgery (treated successfully by partial meniscectomy).
The outcome was judged to be satisfactory, based on frequency of lameness, in 63 (98.4%), while satisfactory outcomes were achieved in 61 (95.3%) based on severity of lameness and in 50 (78.1%) based on mobility score.
Statistical analysis showed that age, bodyweight, tibial plateau angle (TPA), meniscal injury, and concurrent patellar surgery did not influence the outcome, but time to follow-up positively correlated with mobility score (suggesting mobility declined with time from surgery).
The researchers concluded that the long-term (median of 37.5 months) outcome for dogs undergoing TTA-Rapid for cranial cruciate ligament disease is satisfactory, with no risk factors associated with poorer outcomes identified.
The study also revealed no evidence to support the suggestion that dogs with TPAs of greater than 30◦ may be inappropriate candidates for TTA - after testing several parameters to judge outcome including frequency of lameness, severity of lameness, distance walked daily and mobility score.
Steve said: “This research is important in trying to ensure that decisions on whether to use this treatment modality, are based on sound clinical evidence.
"The only factor identified that influenced the outcome measure was that of time since surgery.
"All other factors, including TPA, had no effect on the outcome.”
Vetoquinol has launched Myo Power, the latest addition to the Equistro Performance range of nutritional supplements.
The company says that Myo Power has been formulated with the performance and convalescent horse in mind, and that it is an excellent source of easily digestible protein enriched with L-Leucine and other key essential amino acids necessary for optimal muscular cell development, specifically via the mitochondria.
Vetoquinol claims the product is extremely beneficial for young horses being prepared for sales, competition horses in training, and the convalescent or older horse following periods of box rest or restricted exercise.
Myo Power is available in 1.2kg and 2.3kg tubs. For further information, please contact your local Vétoquinol Territory Manager.
The survey is the second stage of a three stage review recommended to RCVS Council by the College’s Standards Committee in 2019, after it looked at the implications of new technologies for both animal welfare and veterinary regulation.
The main areas under consideration include the provision of 24/7 emergency cover and the interpretation and application of an animal being under the care of a veterinary surgeon. The review also encompasses remote consulting.
In stage one of the review, the RCVS commissioned a research agency to conduct a series of focus group discussions with veterinary professionals working in a variety of roles and sectors. The information gleaned from the discussions was then used to develop the questions for this survey.
The survey will ask veterinary professionals to reflect on what, for them, should underpin good regulations and guidelines for practice.
It will then ask respondents how these principles should be applied in particular situations relating to 24/7 emergency cover and 'under care' before inviting their views on how they would like regulations on these two areas to deal with any tensions between different desirable regulatory aims.
The survey results will be used to help produce any changes to the RCVS Code of Professional Conduct and its supporting guidance concerning ‘under care’ and the provision of 24/7 emergency cover, which will then be put out for full public consultation later this year.
Chair of the RCVS Standards Committee, Dr Melissa Donald, said: “This review addresses fundamental questions about how we should continue to interpret ‘under care’ in a profession, and a society, that is largely unrecognisable to the one that first defined the term, and, at the same time, how we can continue to provide 24/7 emergency cover for those animals under our care.
“The original Vet Futures report also emphasised the impact that technological advances may have on the veterinary professions, so we must ensure we have in place a regulatory framework that gives consideration to these potential changes whilst ensuring animal health and welfare remain at its heart.
“These are challenging but hugely important questions on which we are hoping to receive as much feedback as possible. I do understand the huge pressures my vet and vet nurse colleagues continue to work under at the moment, so would like to thank them in advance for taking a little time out of their busy days to send us their views.”
The survey will open on Wednesday, 19th May 2021 for all UK-based veterinary surgeons and veterinary nurses.
All responses will be used and reported anonymously, so respondents will not be identified.
The survey will be open for four weeks, closing at 5pm on Wednesday, 16 June 2021.
It should take 15-20 minutes to complete, but can be returned to and completed in stages if preferred.
Further background information about the Under Care Review is available at www.rcvs.org.uk/undercare.
The BSAVA has announced that Nottingham Trent University will be the accrediting body for the new Postgraduate Surgery and Medicine Certificates being launched in January 2012.
BSAVA says the planning for this new education initiative has been exhaustive, ensuring that the needs of the profession and the individual vet can be met by a provider with an excellent legacy in veterinary education. And also, an organisation with a genuine interest in seeing the highest scientific standards are matched by a relevant, cost-effective, and accessible programme that fits with life in practice today. To that end, finding the right validation partner was a crucial part of the planning.
Dr Frances Barr, BSAVA Academic Director, said: "This is an exciting new venture in postgraduate CPD, and will ultimately lead to qualifications which are achievable for those in practice and directly relates to their experience. Yet of course, these qualifications must remain challenging enough to merit the respect of the profession and meet the standards of the clinical excellence we all want to see.
"We are confident that BSAVA is the provider to deliver just this, but finding the right partner to validate the programmes was especially important. We want to know that we can move forward with the support and backing of an accrediting body that encourages academic excellence and at the same time understands the need to remain relevant and engaging to busy professionals."
These new qualifications are primarily aimed at veterinary surgeons in small animal practice, who have a particular interest in small animal medicine or surgery. So busy professionals is exactly who they are designed for. This appeals particularly to BSAVA President Andrew Ash, who as well as running the Association heads a six site practice in Sussex. He said: "As an employer I see more and more people who want some recognition for the time they spend fulfilling their professional CPD requirement - and with these discipline-based certificates I can see a way that at any point in your career you can now be rewarded with not only a greater breadth of knowledge and confidence, but with a certificate to show for your efforts.
"I am a great advocate of continual education, and having made a commitment to postgraduate study myself in the past I know how important supported learning is, and how essential it is to have an environment that both acknowledges your other commitments and gives you the support to achieve your ambitions. We are determined to do that.
"Of course I am delighted that this is being launched in my year as President. I am even more delighted that we have Frances Barr to lead this - her experience and enthusiasm is as impressive in this role as it was when she was BSAVA president".
Gill Richards, Director of Professional Development at Nottingham Trent chaired the validation visit at Woodrow House. She said: "Nottingham Trent is especially interested in working with professions in this way to help ensure the quality of provision on postgraduate education for people at all stages of their careers. It was our pleasure to confirm validation today and we look forward to working with the team at BSAVA. It is unusual for anyone to receive the number of commendations that were made today, and what has impressed us most about BSAVA is the impressive quality of the teaching team and materials, and the innovative response to meeting a national demand for a course of this quality".
Enrolment will opening October. The courses will be limited to 30 in each programme. Anyone interested in enrolling for one of these certificate programmes can email academicdirector@bsasva.com or call 01452 726700.